FiercePharmaOriginal article
{"a":[{"_":"J&J’s Tremfya remains on top in Q2 pharma ad spending league as overall outlay drops ","$":{"href":"/marketing/jjs-tremfya-remains-top-q2-pharma-ad-spending-league-overall-spend-drops","hreflang":"en"}}]}
TremfyaNeutral
AI Analysis
Summary
J&J's Tremfya held the top position in Q2 2026 pharma ad spending for a second consecutive quarter, with J&J and AbbVie engaged in continued marketing competition for the second half of 2026.
Importance:2/10
Sentiment:
0.10
marketingad spendingTremfyaimmunology
Related Companies
Read the original article
Published by FiercePharma on July 21, 2026 5:18 AM
